Track topics on Twitter Track topics that are important to you
CRISPR Therapeutics has raised $56 million in an initial public offering, making it the third company developing human medicines with the gene editing system CRISPR-Cas9 to make the IPO leap in 2016. Split between Switzerland and Cambridge, MA, CRISPR Therapeutics sold 4 million shares at $14 apiece, raising about 25 percent less than the target […]
Original Article: CRISPR Therapeutics Raises $56M In IPO, Half Its Rivals’ HaulNEXT ARTICLE
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...